chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SEVERE TINNITUS(FEELING OF CONSTANT FIRE ALARMS IN EARS); HEMATURIA(PRESENCE OF BLOOD IN URINE); DISCOMFORTING TO URINATE; SORE THROAT; SEVERE LEG CRAMPS; LOW APPETITE; NAUSEA; HEADACHE; MUSCLE ACHES; FELT FEVERISH; This spontaneous report received from a patient concerned a 53 year old male. The patient's height, and weight were not reported. The patient's past medical history included: covid-19, and other pre-existing medical conditions included: Patient had no known drug allergies, no current medication usage, and no previous medical conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, expiry: UNKNOWN) dose was not reported, administered on 09-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On OCT-2021, Laboratory data included: Blood test (NR: not provided) Normal, and Urine analysis (NR: not provided) Normal. On 09-OCT-2021, the patient experienced low appetite. On 09-OCT-2021, the patient experienced nausea. On 09-OCT-2021, the patient experienced headache. On 09-OCT-2021, the patient experienced muscle aches. On 09-OCT-2021, the patient experienced felt feverish. On 14-OCT-2021, the patient experienced sore throat. On 14-OCT-2021, the patient experienced severe leg cramps. On 18-OCT-2021, the patient experienced hematuria (presence of blood in urine). On 18-OCT-2021, the patient experienced discomforting to urinate. On 19-OCT-2021, the patient experienced severe tinnitus (feeling of constant fire alarms in ears). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low appetite, nausea, muscle aches, and felt feverish on 13-OCT-2021, and sore throat on OCT-2021, had not recovered from severe tinnitus(feeling of constant fire alarms in ears), and the outcome of headache, hematuria(presence of blood in urine), severe leg cramps and discomforting to urinate was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non-serious
Caused abnormal menstruation. Period came 2 weeks early and was so extremely heavy, I nearly went to the ER for fear of bleeding out. Period is always regular and normally somewhat light.
Itchy, red rash on inner elbow of right arm, tricep of left arm, upper thigh of right leg, top of left foot, right buttocks, and fingers on both hands.
5 minutes post vaccine experienced tingling lips and dry mouth; 5 minutes post vaccine experienced tingling lips and dry mouth; 6 hours followed by lip numbness still occurring (23 hours post vaccine so far); This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO142), via an unspecified route of administration on 06Jan2021 16:45 at single dose at right arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. No known allergies to medications, food, or other products. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine, patient didn't receive other medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. The patient experienced 5 minutes post vaccine experienced tingling lips and dry mouth x 6 hours followed by lip numbness still occurring (23 hours post vaccine so far) with outcome of recovered with lasting effects in Jan2021. Patient received Benadryl 37.5mg x 1 dose for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. The report is considered non-serious.
Patient called pharmacy 2 hrs post vaccine administration stating she was" itching all over" with no other symptoms. She was told to take Benadryl and call her MD.
This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 30-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
red patch on my arm and black and black; nurse put it in below the muscle; Little sore but I still have patch of red on my arm and black and blue; Little sore but I still have patch of red on my arm and black and blue; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 69 year old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 (Batch/Lot Number: EL8982) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing Verbatim: High cholesterol. Concomitant medication(s) included atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient experienced red patch on her arm and black and black rash on an unspecified date with outcome of unknown, nurse put it in below the muscle causing product use issue on an unspecified date with outcome of unknown, little sore but she still have patch of red on her arm and black and blue causing vaccination site bruising on an unspecified date with outcome of unknown, vaccination site pain on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included weight:of about 185 Pounds.  Upon Follow-up (09Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported that: The patient has high cholesterol, Batch/LOT number was updated, concomitant medications included Atorvastatin 40mg taken once a day. The patient weight and adverse events were added.   No follow-up attempts are possible. No further information is expected.
Extreme fatigue starting about 24 hrs after shot, still going on 4 days later, today.  Fever 98.6, normally under 97.6 during the day.  Sniffly. Headaches yesterday and today (10/23-10/24).  Will call doctor if still feeling bad Monday (10/25).  This was booster shot; previous doses were 2/11/21 and 3/7/21.
The patient has a history of AML diagnosed in June 2022 and currently on chemo. He was seen in the ED on 4/23/23 for fever, decrease in energy level, and decrease in appetite. Chest x-ray showed findings suggestive of left lobar pneumonia. Ultimately, he was admitted 4/23/23 - 5/1/23. A respiratory pathogen panel performed on 4/28/23 resulted positive for COVID-19. Given no infiltrates on imaging and the patient was not hypoxic, per the provider he did not meet criteria for either dexamethasone or remdesivir. Discharge diagnoses included neutropenic fever, COVID infection without hypoxia, and suspected CAP, among other diagnoses. Of note, the patient has received the primary COVID-19 vaccine series and one booster. The lot number of the most recent vaccine is unknown.
Approx 1 minute after receiving vaccine - patient felt excruciating pain in arm, and almost lost consciousness. Pt was sat down and given emesis basin due to severe nausea. Symptoms subsided after approx 10 minutes. Member deferred from future anthrax vaccine.
Tinnitis since vaccination, moderately severe and not a sufferer of Tinnitis in this long of term period before.
another gushing nose bleed; minor nose bleed; fourth nose bleed; third severe nose bleed; second severe nose bleed; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (second severe nose bleed), EPISTAXIS (third severe nose bleed), EPISTAXIS (fourth nose bleed) and EPISTAXIS (another gushing nose bleed) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Von Willebrand's disease.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced EPISTAXIS (second severe nose bleed) (seriousness criterion disability). On 25-Feb-2021, the patient experienced EPISTAXIS (third severe nose bleed) (seriousness criterion disability). On 09-Mar-2021, the patient experienced EPISTAXIS (fourth nose bleed) (seriousness criterion disability). On 13-Mar-2021, the patient experienced EPISTAXIS (minor nose bleed). On 18-Mar-2021, the patient experienced EPISTAXIS (another gushing nose bleed) (seriousness criterion disability). On 13-Mar-2021, EPISTAXIS (minor nose bleed) had resolved. In March 2021, EPISTAXIS (fourth nose bleed) had resolved. On 18-Mar-2021, EPISTAXIS (another gushing nose bleed) had resolved. At the time of the report, EPISTAXIS (second severe nose bleed) and EPISTAXIS (third severe nose bleed) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Computerised tomogram head: normal (normal) Normal frontal sinuses, nose, and frontal lobe of brain.         Concomitant product use was not reported. Treatment for the nose bleeds included intravenous desmopressin, aminocapriotic acid, cauterization, and packing.; Sender's Comments: This case concerns a 69 Y/O F with multiple serious unexpected events of severe epistaxis.  Event onset 8 days after first dose mRNA-1273. Treated with desmopressin, aminocapriotic acid, cauterization. Events resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received on 19-JUL-2017 regarding a case in litigation regarding a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported), subcutaneous as recommended for routine adult health maintenance and for the prevention of shingles at a pharmacy. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 23-MAY-2016, the patient was treated by a physician in a physician's office for a painful and blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. On or about 23-SEP-2016, the patient was treated again by a physician in a physician's office for continuing and worsening symptoms, which was then diagnosed as post herpetic neuralgia, a chronic condition of residual nerve damage and pain secondary to shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
15 hrs. after injection pt. C/O (L) shoulder pain - not radiating, C/O numbness sensation in (L) upper extremity down to his left elbow, no fever.
pt recv vax 3AUG95 & broke out in full blown case of chickenpox JAN99 per parent-not mild case per mom over200 pox on body;
Fever of 101, chills. Body aches, headaches, exhaustion. Only lasted 24 hours. Took Tylenol and slept it off. Also drank lots of water.
PATIENT SHOWED UP FOR THE APPOINTMENT FOR HER 2ND DOSE. WHILE GOING THROUGH THE , EVEN THOUGH PATIENT (PARENT) MARKED NO ALLERGIES, I ALWAYS STILL RECONFIRM WITH PATIENT THAT THERE IS NO ALLERGY. PATIENT WITH HER PARENT (MOM AND DAD) PRESENT INDICATED THAT SHE HAD LOST LIP COLOR (PALE), VOMITING, DIZZINESS, SHORTNESS OF BREATH. PATIENT  WENT TO THE ER AND HER BLOOD PRESSURE WAS LOW AND HAD IV GIVEN TO HER. SHE WAS RELEASED THE SAME DAY. PATIENT DID NOT CALL THE PHARMACY AFTER THE REACTION.  PATIENT IS ALSO NOT SURE IF THE ER HAD REPORTED IT.  FOR THIS REASON WE ARE REPORTING THIS EVENT.
One week after receiving  the vaccine my left knee became painful and swollen.  I had the same thing happen  one week after the first  dose only it mostly effected my right knee.   The pain and swelling  lasts about  2 weeks plus.  When it  happened to my right knee I thought it was because of previous surgery (ACL) 25 years ago.  I have pain in my right knee from time to time, but I have not had a problem with my left knee and no history of injury.
Patient received first dose Pfizer 5/5/21, second dose Moderna   5/26/2021. Troubleshooting: Scribe and vaccinator did not look at card to see what was given prior; AMR staff investigated and addressed the error.  Pt was counseled
Kawasaki disease - Mucocutaneous lymph node syndrome, rash skin, red tongue, eyes red, back skin blood red spot, feet swell, neck swell, hands EKG, Xray fever 103 degrees - 105 degrees - 3 days diarrhea (IGIV).
Still suffering from pain from behind my knees, mostly right knee but both affected. Knees hurt when I sleepwalk or bend.; Initially I was very sick with body aches for 24 hours; Still suffering from pain from behind my knees, mostly right knee but both affected. Knees hurt when I sleepwalk or bend.; Still suffering from pain from behind my knees, mostly right knee but both affected. Knees hurt when I sleepwalk or bend.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 at 10:30 as dose 5 (booster), single (Lot number: GH9702) at the age of 72 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Shrimp" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN; RAMIPRIL. Past drug history included: Levaquin, reaction(s): "Known allergies: Levaquin". Vaccination history included: Covid-19 vaccine (Dose:4, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose:3, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose:2, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose:1, Unknown manufacturer), for COVID-19 Immunization. The following information was reported: ILLNESS (non-serious) with onset 16Sep2022 at 20:00, outcome "recovered" (Sep2022), described as "Initially I was very sick with body aches for 24 hours"; SOMNAMBULISM (non-serious), PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 16Sep2022 at 20:00, outcome "not recovered" and all described as "Still suffering from pain from behind my knees, mostly right knee but both affected. Knees hurt when I sleepwalk or bend.". Therapeutic measures were not taken as a result of somnambulism, illness, pain, arthralgia.  Additional information: No other vaccine given in four week. No covid prior vaccination. No covid tested post vaccination. Other medical history none.
high fever; chills; headache; slight joint aching; Woke up at 3am post-vaccination feeling nauseous, then went back to sleep; Slept all day; Still feel very sick; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 26-year-old non pregnant female patient received 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in left arm on 17Feb2021 13:15 (vaccination at the age of 26 years) as dose 2, single for COVID-19 immunization at Workplace clinic. The patient medical history was none. Patient was had no known allergies. Concomitant medications in two weeks included ethinylestradiol, norgestimate (ESTARYLLA), valaciclovir (VALACICLOVIR), cyanocobalamin (B12 [CYANOCOBALAMIN]), colecalciferol (D3), iron (IRON) all taken for an unspecified indication, start and stop date were not reported. Patient historically received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in left arm on 26Jan2021 13:15 (vaccination at the age of 26 years) as dose 1, single for COVID-19 immunization at Workplace clinic. On 18Feb2021 03:00 AM, patient experienced feeling nauseous and at 07:00 AM patient experienced high fever, chills, nausea, headache, slight joint aching. Reportedly, slept all day and felt very sick. Reportedly, the patient woke up at 3am post-vaccination feeling nauseous, then went back to sleep. The patient woke up at 7 am with fever, chills, nausea, headache, slight joint aching. 4:30pm filling this out. Slept all day. Still feel very sick. Three other colleagues and her department out sick after second vaccine with same symptoms (received 17Feb2021) on 18Feb2021. Upon return to site on 22Feb2021, she learned that it was a total of at least six employees in my department out sick with similar symptoms out 18Feb2021 or/and 19Feb2021. Patient stated, four of us all woke up between 2-3am with noticeable symptoms, including high fever and chills. Please note that 5/6 mentioned employees are in our mid 20s to early 30s in age (in case there's a trend). We have all since recovered. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior vaccination. The patient was not tested for COVID post vaccination. No therapeutic measures were taken as a result of the events. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Patient was 17 at time of vaccine administration. No adverse reaction in 15 following vaccination.
Adverse Flu-Like symptoms occured the following afternoon after recieving Dose 2 of the Moderna vaccine.  Symptons include chills, severe muscle and joint aches, mild grade fever.  Symptoms have lessen on the morning of 4/23/2021, but I still feel winded.
Headache, Myalgia, Arthralgia & Fever Narrative:  Fever 101.2, arthralgia, myalgia, headache; taking ibuprofen.
Patient had dizziness and tunnel vision-felt faint. 911 was called.  EMT checked vitals, decided she was stable and left. PT stayed with nurse until BP returned to normal and nurse advised taking the rest of the day off and calling 911 if she experiences any other issues.  PT indicated she hasn't had a flu shot since she was 8 yrs old and does often feel faint when having blood drawn or receiving shots.
Nerve pain radiating from injection site through nerves in arm, elbow,  wrist, hand and fingers
615 c/o sharp chest pain; 640Pm c/o heaviness in chest, SOB difficulty breathing-hyperventilating lead to numbness around mouth & hands & feet; hx of asthma but no attacks this bad before; 02 in ambulance relieved sx; resp still rapid in ER
Later in the evening after receiving the J&J vaccine, I developed a 103 degree fever, severe chills, headache, fatigue, and mild nausea/upset stomach.  I tried to hold off for a bit from taking any pain relievers, but did take tylenol about halfway through the night which helped quite a bit. The next day I only had a low grade fever, fatigue and minor stomach upset. I also had some arm pain starting that evening post vaccination and it lasted for about 5 days. I felt mostly fine though within a couple days. I am one week post vaccination and currently feel pretty good. I have been sleeping heavier/more this week but I'm not sure whether it's related or not.
10 min post vaccine administration patient had episode of dizziness that resolved without treatment. Client returned to health dept 1 hour later with dizziness and facial flushing no other symptoms. PMD notified advised patient to go home, rest, take 1- 2 po benadryl 25 mg PRN. Spouse with patient. No symptoms at discharge approx 20 min
Fainted; Dizziness; Sweaty palms; Heart rate dropped; Weird burning sensation in the back of his neck with tension; Weird burning sensation in the back of his neck with tension; Disorientated; Lost his color; Weird sensation in throat; Headache; Had pressure in his ears; Gassy; This is a spontaneous report from a contactable consumer (mother of the patient). A 17-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8731; Expiration date was not reported) on 15Apr2021 (15:00) as a single dose, with route of administration unspecified, for COVID-19 immunization at the clinic (not a military facility). The patient had no relevant medical history and concomitant medications. On 15Apr2021, after the first dose of vaccination, the patient had fainted; dizziness; sweaty palms; heart rate has dropped; had weird burning sensation at the back of the neck with tension; was disorientated; and had lost his color. In Apr2021, the patient had weird sensation in the throat; headache; had pressure in his ears; and was gassy. The outcome of the events was unknown for 'lost his color'; was not recovered for 'headache'; and was recovered on an unspecified date in 2021 for all the other events.  Information on lot/batch number was available. Additional information has been requested.
Employee received vaccine at 9:10 am and left the facility to return to work shortly after. Employee drove approximately 16 blocks and felt like her blood pressure was dropping. Employee was having a difficult time breathing. Employee parked her car into a parking lot. Employee had liquid BENADRYL with her and took 5 mls. Employee called 911 for assistance. The 911 connected employee to the local fire department. The fire department provided information regarding the closest hospital locations. Employee then called her supervisor who directed employee to return to the employee immunization clinic. Employee returned to the clinic at 9:45 am. Employee was assessed by this nurse. Vital signs at 10:00 am: Blood pressure: 118/78, pulse: 64, respirations: 16. Breathing was normal, skin: cool, clammy and intact. Employee was able to talk and swallow normally. Patient alert and oriented to person, place and time. Vital signs repeated at 10:20 am: B/P: 108/68, pulse 60, respirations: 16, skin: warm, dry and intact. Employee oriented to person, place and time. V/S at 11:00 am: B/P: 104/62. pulse: 64, respirations: 16, skin warm, dry and intact. Employee oriented to person, place and time.
fever; chills; ached all over; headache; diarrhea; This is a spontaneous report from a contactable Consumer. An elderly non-pregnant female patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection), via an unspecified route of administration, administered in Arm Left on 03Feb2021 11:00 (Batch/Lot Number: EJ16986) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 04Feb2021, the patient started with headache in morning then diarrhea in the evening. On 05Feb2021, patient had fever, chills and ached all over. Next day felt much better. The patient did not receive treatment for AEs. The outcome of events was recovering.   Follow-up attempts completed. No further information expected.
Body-wide rash with blistering and itching. Still breaking out over a month later. Has had multiple rounds of oral and topical steroids